Immutep (IMMP) Profit After Tax (2011 - 2024)
Immutep (IMMP) posted Profit After Tax of -$14.6 million for Q4 2024, up 48.02% on a QoQ basis from -$28.2 million in Q2 2024, and down 5.89% year-over-year from -$15.6 million in Q1 2024.
Immutep (IMMP) Profit After Tax (2011 - 2024) Analysis & Trends
Immutep's Profit After Tax history runs 14 years deep, the most recent figure standing at -$14.6 million for Q4 2024.
- Quarterly Profit After Tax fell 5.89% year-over-year to -$14.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$83.3 million (down 26.38% YoY) and the FY2025 annual result came in at -$39.3 million, down 39.76% from the prior year.
- Profit After Tax was -$14.6 million for Q4 2024 at Immutep, up from -$28.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$8.8 million in Q2 2020 and bottomed at -$28.2 million in Q2 2024.
- A 5-year average of -$16.8 million and a median of -$13.8 million in 2023 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2020 — Profit After Tax soared 31.3% — and 2022, when it decreased 14.32%.
- Immutep's Profit After Tax stood at -$8.8 million in 2020, then slumped by 34.27% to -$11.9 million in 2021, then declined by 14.32% to -$13.5 million in 2022, then dropped by 1.99% to -$13.8 million in 2023, then fell by 5.89% to -$14.6 million in 2024.
- Business Quant data shows IMMP's Profit After Tax at -$14.6 million in Q4 2024, -$28.2 million in Q2 2024, and -$13.8 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -14.63 Mn |
| Jun 30, 2024 | -28.15 Mn |
| Dec 31, 2023 | -13.82 Mn |
| Jun 30, 2023 | -26.67 Mn |
| Dec 31, 2022 | -13.55 Mn |
| Dec 31, 2021 | -11.85 Mn |
| Jun 30, 2020 | -8.83 Mn |
| Dec 31, 2019 | -4.07 Mn |
| Jun 30, 2019 | -12.85 Mn |
| Dec 31, 2018 | -6.23 Mn |
| Jun 30, 2017 | -1.99 Mn |
| Mar 31, 2017 | -1.80 Mn |
| Dec 31, 2016 | -3.05 Mn |
| Jun 30, 2016 | -46.31 Mn |
| Mar 31, 2016 | -1.99 Mn |
| Jun 30, 2015 | -25.00 Mn |
| Jun 30, 2014 | -12.44 Mn |
| Jun 30, 2013 | -15.13 Mn |
| Dec 31, 2012 | -8.34 Mn |
| Jun 30, 2012 | -20.15 Mn |